Clinical Trial

Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Phase I, Single-Center, Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Effect of High-Fat and Low-Fat Meals on the Pharmacokinetics of FWD1802 in Chinese Healthy Subjects. The primary objectives are to address the following questions: To evaluate the impact of high-fat and low-fat meals on the pharmacokinetic (PK) characteristics of a single oral dose of FWD1802 in healthy Chinese Subjects.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-07-17
notable Primary completion pushed: 2026-05 -> 2026-07-06 2026-07-17
minor Completion pushed: 2026-08 -> 2026-09 2026-07-17
Trial Details
NCT Number NCT07476963
Lead Sponsor Forward Pharmaceuticals Co., Ltd.
Conditions Healthy
Enrollment 18 participants
Start Date 2026-03-15
Primary Completion 2026-07-06 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-16